This security is no longer actively traded. Historical data is preserved for reference.No holders in 2025-Q4, no recent price data
GEVA·87159A103·US·equity·Unknown - Unknown
GEVA (SYNAGEVA BIOPHARMA CORP) is held by 0 institutional investors as of Q2 2015.
No institutional consensus yet
Fewer than 2 tracked funds currently hold GEVA (SYNAGEVA BIOPHARMA CORP). We surface convergence signals once 2+ institutional funds, insiders, or activists take a position.
This is the correct empty state for thinly-held stocks, not a data issue. New 13F filings arrive quarterly; insider and activist filings update daily.
Fund | Action | Shares | Value | Weight | Est. P&L | Conviction |
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $1.8M | 0.0% | — | 0 |
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer
